Endometrial adenocarcinoma or cancer of the uterine corpus accounts for more than 80% of endometrial cancers and is one of the most common female genital tract malignancies. Obesity, nulliparity, tamoxifen therapy, long-term unopposed estrogen action, genetic predisposition, and hyperinsulinemia are supposed to be risk factors associated with it.
Cancerous tumors in the uterine corpus are called endometrial cancers as 92% occur in the endometrium  and more than 80% of these are endometrial adenocarcinomas.
Although most endometrial cancers are diagnosed in the elderly with a median age of 65 years , it is also seen in younger women . It presents commonly with abnormal uterine bleeding or spotting, dysuria (pain during urination), and dyspareunia. In 90% of endometrial cancer patients, uterine bleeding is the only symptom  and this cardinal presentation leads to an early diagnosis of the condition. Rarely, abnormal cervical cytology is the first clue to the presence of a uterine corpus malignancy in asymptomatic women. In perimenopausal women, the menstrual periods appear further apart and become scantier and so, any intermenstrual bleeding or heavy frequent menses should raise a cause for concern. In postmenopausal women, unprovoked vaginal bleeding may be the first symptom of endometrial adenocarcinoma.
Several risk factors have been reported to be associated with the development of endometrial adenocarcinoma and these are endometrial hyperplasia, obesity, hormonal treatment  , tamoxifen medication  , early menarche, late menopause or polycystic ovarian syndrome (PCOS) -conditions associated with prolonged unopposed estrogen effect, genetic predisposition  , hyperinsulinemia .
Entire Body System
Grade 3 TRAEs occurred in 16.7% and included asthenia and back pain; anemia, hyperglycemia, and hyponatremia; chills and pyrexia; diarrhea. There were no grade 4 or 5 events, and no immune-related adverse events were reported. [cancertherapyadvisor.com]
In advanced stages, symptoms include intense pain, weight loss and anemia (low red blood cell count) Causes and Risk Factors The following factors may put a woman at higher risk of developing endometrial cancer: Being older than 40 years old (Less than [cedars-sinai.edu]
Common side effects include: Dry, reddened skin in the treated area Fatigue Diarrhea Discomfort when urinating Narrowing of the vagina Anemia Most of these side effects are temporary. [foundationforwomenscancer.org]
Complications may include any of the following: Anemia due to blood loss (before diagnosis) Perforation (hole) of the uterus, which may occur during a D and C or endometrial biopsy Problems from surgery, radiation, and chemotherapy Call for an appointment [nlm.nih.gov]
They commonly occur in elderly females presenting with vaginal bleeding, pain, weight loss, and abdominal mass. ,  The unusual finding in our case was the absence of vaginal bleeding. [cancerjournal.net]
Pelvic and abdominal CT are also done to check for extrauterine or metastatic cancer in patients with any of the following: An abdominal mass or hepatomegaly detected during physical examination Abnormal liver function test results A high-risk histologic [merckmanuals.com]
Because of recent use of dabigatran and vaginal bleeding she underwent treatment with full-dose radiation and brachytherapy. Adenocarcinoma following supracervical hysterectomy is a rare occurrence. [ncbi.nlm.nih.gov]
We present the case of a 65-year-old patient who presented with association of pelvic pain, enlarged uterine cavity with an underlying hematometra and an irregular, thickened endometrium who was submitted to surgery for total histerectomy, bilateral adnexectomy [ncbi.nlm.nih.gov]
Other symptoms include unusual pelvic pain or pressure, difficult or painful urination, and pain during intercourse. [breastcancer.org]
The symptoms of uterine cancer include Abnormal vaginal bleeding or discharge Trouble urinating Pelvic pain Pain during intercourse Uterine cancer usually happens after menopause. It is more common in women who have obesity. [medlineplus.gov]
Usually the bleeding is painless, but sometimes it can be associated with other symptoms, including: Pelvic pain or cramping (That's the area where the uterus is located.) [study.com]
pain; pelvic mass; weight loss. [myriadmyrisk.com]
uterus that microscopically exhibits ectopic, non-neoplastic endometrial glands and stroma, surrounded by hypertrophic and hyperplastic myometrium ( 1 ). [ncbi.nlm.nih.gov]
After a thorough evaluation by an Ob/Gyn, the patient was found to have an enlarged uterus, a large fibroid, fluid in the endometrial cavity, and a growth in the lining of the uterus that was about an inch thick. [thedoctorwillseeyounow.com]
Rarely patients may present with an enlarged uterus or pelvic mass in the absence of bleeding. It should also be noted that 25% of patients with endometrial cancer are premenopausal and about 5% are under the age of 40. [clinicaladvisor.com]
This is a report on the coexistence of a uterine adenomatoid tumor and an endometrial adenocarcinoma, both chance findings in a 41-year-old woman undergoing hysterectomy because of a preoperative diagnosis of metrorrhagia due to leiomyomas. [ncbi.nlm.nih.gov]
Symptoms and Signs Most ( 90%) women with endometrial cancer have abnormal uterine bleeding (eg, postmenopausal bleeding, premenopausal recurrent metrorrhagia); one third of women with postmenopausal bleeding have endometrial cancer. [merckmanuals.com]
It presents commonly with abnormal uterine bleeding or spotting, dysuria (pain during urination), and dyspareunia. [symptoma.com]
[…] ovarian cysts might experience any of the following symptoms: Menstrual irregularities or abnormal bleeding Dull ache in your lower back or thighs Pelvic pain shortly before or after the beginning of your menstrual cycle Pelvic pain with intercourse (dyspareunia [innovativegyn.com]
As endometrial adenocarcinomas can occur in peri as well as postmenopausal women, heavy menstrual bleeding or intermenstrual bleeding, irrespective of amount or duration, should be thoroughly investigated. It is important to elicit a detailed menstrual history, intake of contraceptive pills, hormonal therapy (for PCOS etc), hyperinsulinemia, and a family history of endometrial malignancy. Physical examination includes an examination of the pelvis, uterus, cervix and vagina as well as the inguinal region for lymphadenopathy. In most cases the uterine size is normal and no gross abnormalities are noticed.
Transvaginal ultrasonography is performed to detect abnormal endometrial thickening as it has good sensitivity  and this can be further confirmed with hydro ultrasonography i.e ultrasonography after injection of saline in the uterine cavity. If the abnormal endometrial thickness is detected, then routine laboratory studies, electrocardiogram and chest radiography should be obtained as part of the preoperative assessment. The patient is examined under anesthesia and an endometrial or hysteroscopic biopsy can be obtained for histopathological examination and final confirmation of endometrial adenocarcinoma. Further staging of the tumor may require a laparotomy to detect extrauterine spread and lymph node involvement.
Prognostic biomarkers like estrogen receptor (ER) and progesterone receptor (PR) are also tested as endometrial tumors associated with these markers are reported to have a good prognosis . Immunohistochemistry to identify the absence of phosphatase and tensin homolog (PTEN) marker, a tumor suppressor, has also been reported as a sensitive method to predict cell proliferation and survival .
Because any condition that increases exposure to unopposed estrogen increases the risk of endometrial cancer, tamoxifen therapy, estrogen replacement therapy without progestin and the presence of estrogen-secreting tumors are all risk factors. [aafp.org]
Hormone replacement therapy and estrogen: Either oral or body-produced estrogen increases the risk of this cancer. Environmental chemicals: Pesticides and air pollution have a direct effect on the risk of endometrial cancer. [vitamindcouncil.org]
There have been several reports about successful fertility-preserving treatment of endometrial carcinoma with subsequent pregnancy. However, conservative hormonal treatment for early-stage endometrial cancer still entails some risk. [ncbi.nlm.nih.gov]
OBJECTIVE: To study the association between metabolic syndrome (MS) and the prognosis of patients with endometrial adenocarcinoma. [ncbi.nlm.nih.gov]
PURPOSE: Endometrial cancer can be divided into two types: endometrioid Type 1 (G1, G2) has a hormonal driven etiology, while Type 2 is more aggressive (G3 endometrioid, clear cell and serous cancer type) and estrogen independent. [ncbi.nlm.nih.gov]
Brinton LA, Felix AS, McMeekin DS, Creasman WT, Sherman ME, Mutch D et al (2013) Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. [link.springer.com]
[…] of the cases among other histologic types, type I includes mucinous and secretory carcinomas, whereas type II includes clear-cell carcinomas and adenosquamous carcinomas Embryonic origin tumour developped from the epithelium of the endometrial mucosa Etiology [atlasgeneticsoncology.org]
GYNECOLOGIC NEOPLASMS ENDOMETRIAL CANCER Etiology and Pathology Symptoms, Signs, and Diagnosis Staging, Prognosis, and Treatment OVARIAN CANCER Etiology and Pathology Symptoms, Signs, and Diagnosis Treatment CERVICAL CANCER Pathology Symptoms and Signs [health.am]
METHODS AND MATERIALS: Data between 1998 and 2011 from the National Cancer Institute's Surveillance, Epidemiology and End Results database were analyzed. [ncbi.nlm.nih.gov]
The chapters are comprehensive and logically organized, covering the epidemiology and pathogenesis of endometrial adenocarcinoma, endometrial sampling techniques and the spectrum of cytomorphologic appearance from benign through hyperplasia to adenocarcinoma [karger.com]
We discuss the epidemiology, diagnosis, and treatment of endometrial cancer on the basis of a review of observational research, randomised trials, reviews, and meta-analyses. [bmj.com]
Recent association between first-trimester spontaneous abortions and subsequent endometrial cancer makes these rare cases of concurrent endometrial cancer and first trimester of pregnancy attractive in that they may disclose insights into the pathophysiology [ncbi.nlm.nih.gov]
Overview Historical Perspective Classification Pathophysiology Causes Differentiating Endometrial Cancer from other Diseases Epidemiology and Demographics Risk factors Screening Natural History, Complications and Prognosis Diagnosis Staging History and [wikidoc.org]
The book emphasizes the correlation between clinical and pathologic features of female genital tract disease by examining the pathophysiology of individual organ systems. [books.google.ro]
[…] post-menopausal woman with an intact uterus) tamoxifen treatment Hereditary Nonpolyposis Colon Cancer (HNPCC or Lynch Syndrome) on family history factors that decrease risk include: ovulation OCP progestin menopause normal weight multiparity smoking return to top Pathophysiology [sharinginhealth.ca]
Abstract Diethylstilbestrol (DES) was used widely in the late 1940s in an attempt to prevent adverse pregnancy outcomes. [ncbi.nlm.nih.gov]
- American Cancer Society: Cancer Facts and Figures 2016. Atlanta, Ga: American Cancer Society, 2016. http://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2016/cancer-facts-and-figures-2016.pdf. Accessed January 23, 2016
- Huang CY, Chen CA, Chen YL, et al. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan. PloS One. 2012; 7: 51372.
- Park JY, Seong SJ, Kim TJ, et al. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol. 2013;121:136-42.
- Colombo N, Preti E, Landoni F, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2011; 22: 35-9.
- Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975; 293 (23): 1167-70.
- Jick SS, Walker AM, Jick H. Estrogens, progesterone, and endometrial cancer. Epidemiology 1993; 4 (1): 20-4
- van Leeuwen FE, Benraadt J, Coebergh JW, et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet. 1994;343 (8895): 448-52
- Fisher B, Costantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst. 1994;86 (7): 527-37
- Lynch HT, Lynch J, Conway T, et al. Familial aggregation of carcinoma of the endometrium. Am J Obstet Gynecol 1994; 171 (1): 24-7
- Lu KH, Schorge JO, Rodabaugh KJ, et al. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. J Clin Oncol. 2007; 25 (33): 5158-64
- Nead KT, Sharp SJ, Thompson DJ, et al. Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis. J Natl Cancer Inst. 2015;107 (9)
- Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities, JAMA. 1998;280(17):1510–1517.
- Ferrandina G, Ranelletti FO, Gallotta V, et al. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer, Gynecol Oncol, 2005, 98(3):383–389.
- Djordjevic B, Hennessy BT, Li J, et al. Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing. Mod Pathol. 2012; 25(5):699–708.